

HY-145931 · Free Sample (0.1 - 0.2 mg)
MedChemExpress · Cat: HY-145931
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/cc214-2.htmlDescription
CC214-2 is an oral active and selective mTOR kinase inhibitor. CC214-2 targets to both of mTORC1 pS6 and mTORC2 pAktS473 . CC214-2 induces autophagy, which is a potential target for host-directed therapy HDT in tuberculosis. CC214-2 exhibits synergistic bactericidal and sterilizing activity agasinst tuberculosis TB , and shortens the treatment duration. CC214-2 also inhibits Rapamycin HY-10219 -resistant signaling and the growth of glioblastomas in vitro and in vivo.







